February 2014
Regular 7pm Meeting, February 12th:Join 2014 Facilitators Marty and Kim to speak about the four current 'standard of care' HCV treatment regiments.
Future 2014 meetings:Gilead Sciences, manufacturer of Sovaldi, has agreed to speak at our May 2014 meeting about their FDA approved products, some FDA labelled without peginteferon alpha.
Prospects for other 2014 meetings:
Transplant surgeon, attorneys, psychiatry professional, massage therapy education and treatment experiences, are some of the ideas on the table.
Today's Date:
What States are doing